Cryosupernatant and solvent detergent fresh-frozen plasma (Octaplas) usage at a single centre in acute thrombotic thrombocytopenic purpura.
about
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical useIs solvent/detergent plasma better than standard fresh-frozen plasma? A systematic review and an expert consensus documentInvestigational drugs in thrombotic thrombocytopenic purpura.Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.Management of pregnancy-associated thrombotic thrombocytopenia purpura.Characterization of the complications associated with plasma exchange for thrombotic thrombocytopaenic purpura and related thrombotic microangiopathic anaemias: a single institution experience.Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: a single center retrospective evaluation.Cryosupernatant and Immunosuppression as Effective Alternative Therapies for TTP in Three Pediatric SLE Patients.Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP/thrombotic microangiopathy registry.A single-center prospective study on the safety of plasma exchange procedures using a double-viral-inactivated and prion-reduced solvent/detergent fresh-frozen plasma as the replacement fluid in the treatment of thrombotic microangiopathy.Efficacy and Safety Profile of Solvent/Detergent Plasma in the Treatment of Acute Thrombotic Thrombocytopenic Purpura: A Single-Center ExperienceThe Use of Solvent/Detergent Treatment in Pathogen Reduction of Plasma.Management of thrombotic thrombocytopenic purpura: current perspectivesThe use of therapeutic apheresis in cardiovascular disease.Solvent/detergent plasma: pharmaceutical characteristics and clinical experience.Solvent/detergent-treated plasma: a tale of 30 years of experience.The aspirin story - from willow to wonder drug.The impact of whole blood processing and freezing conditions on the quality of therapeutic plasma prepared from whole blood.Two approaches to the clinical dilemma of treating TTP with therapeutic plasma exchange in patients with a history of anaphylactic reactions to plasma.Recovery, safety, and tolerability of a solvent/detergent-treated and prion-safeguarded transfusion plasma in a randomized, crossover, clinical trial in healthy volunteers.
P2860
Q26741073-ACBB72EE-46C7-4C03-907C-789A335919B9Q26748355-2A40F410-CBA0-449C-8800-D4C6650218F2Q33395696-13830A0F-65DA-45CB-9B85-B9161FF1CF2AQ33401403-ED9B904D-FB38-4693-B87C-22464E40D0F1Q33409773-A7961472-EA52-49E0-A439-E6EACDDD4718Q33410864-40E4429D-A197-4BEF-87A9-6884106B942DQ33415693-A14729ED-19E8-4105-9974-9F25E5DD7876Q33418313-F7EDA712-8A0C-4871-96E5-0CDB7889689FQ33426823-28370B0A-37F2-4D85-9122-CD50A24C29C1Q33436241-74E0FF49-D3E9-48F7-9540-C9193F4896C8Q34038164-C9EF4DA1-2420-4B30-9C1A-C45C72CB03BBQ35095666-F015F4B3-DFA8-4C9E-BA0A-D5E93A2CF5D6Q37577785-8C23C8B6-63AA-426B-9044-C300C0323D09Q38203567-48C3F479-E140-43A4-9236-8581BADC88E6Q38213153-394AF622-57D3-47AC-AC94-B3431EDDC93EQ38361191-725EEB6F-B6CE-4C04-B5CA-220E537A2C19Q38768065-678BA9B5-CD6E-4339-B4DF-4DD689F53418Q45412520-BACF65C3-96BC-483C-8116-106D9287699CQ47425286-24809F27-13FC-4C8A-A983-44113B8D80ABQ50109567-02D4AE52-D851-4DE1-8D06-C31AA1B4C8A7
P2860
Cryosupernatant and solvent detergent fresh-frozen plasma (Octaplas) usage at a single centre in acute thrombotic thrombocytopenic purpura.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Cryosupernatant and solvent de ...... otic thrombocytopenic purpura.
@ast
Cryosupernatant and solvent de ...... otic thrombocytopenic purpura.
@en
type
label
Cryosupernatant and solvent de ...... otic thrombocytopenic purpura.
@ast
Cryosupernatant and solvent de ...... otic thrombocytopenic purpura.
@en
prefLabel
Cryosupernatant and solvent de ...... otic thrombocytopenic purpura.
@ast
Cryosupernatant and solvent de ...... otic thrombocytopenic purpura.
@en
P2093
P2860
P1433
P1476
Cryosupernatant and solvent de ...... otic thrombocytopenic purpura.
@en
P2093
P2860
P304
P356
10.1111/J.1423-0410.2007.00940.X
P577
2007-08-01T00:00:00Z